Malignant neoplasm of pituitary gland
ICD-10 C75.1 is a billable code used to indicate a diagnosis of malignant neoplasm of pituitary gland.
Malignant neoplasm of the pituitary gland is a rare but serious endocrine malignancy that arises from the cells of the pituitary gland, which is responsible for producing and regulating various hormones that control critical bodily functions. These tumors can disrupt normal hormone production, leading to a range of metabolic and physiological disturbances. Symptoms may include headaches, vision changes, and hormonal imbalances, such as Cushing's disease or acromegaly, depending on the type of hormone secreted by the tumor. Diagnosis typically involves imaging studies like MRI and hormonal assays to assess pituitary function. Treatment often requires a multidisciplinary approach, including surgical resection, radiation therapy, and pharmacological management to control hormone levels. The prognosis varies based on tumor size, type, and response to treatment, making early detection and accurate coding essential for effective management and reimbursement.
Thorough documentation of hormonal assays, imaging studies, and clinical symptoms.
Patients presenting with symptoms of hormonal excess or deficiency, such as Cushing's syndrome or pituitary apoplexy.
Endocrinologists must ensure that all hormonal levels are documented, as they are critical for accurate coding and treatment planning.
Detailed operative reports and post-operative follow-up notes.
Surgical intervention for pituitary tumors, including transsphenoidal resection.
Neurosurgeons should document the extent of resection and any complications to support coding for malignancy.
Used during surgical intervention for malignant pituitary tumors.
Operative report detailing the procedure and findings.
Neurosurgeons must document the extent of resection and any complications.
Common symptoms include headaches, visual disturbances, hormonal imbalances, and signs of increased intracranial pressure.
Diagnosis typically involves MRI imaging, hormonal assays, and sometimes biopsy to confirm malignancy.
Treatment options include surgical resection, radiation therapy, and medications to manage hormone levels.
